NUT-midline carcinoma of the lung with rare BRD3-NUTM1 fusion-Reference-Cited by-同舟云学术

NUT-midline carcinoma of the lung with rare BRD3-NUTM1 fusion

Published:2024-01 Issue:1 Volume:7 Page:110-116
ISSN:2590-3233
Container-title:Cancer Research, Statistics, and Treatment
language:en
Short-container-title:

Author:

Jha Prerana¹²,Trivedi Vaishakhi²,Menon Nandini³,Shah Minit³,George Irene A⁴⁵,Mishra Rohit²,Pai Trupti⁶,Ahmad Fuzail²,Ramachandran Venkataramanan¹²,Noronha Vanita³,Prabhash Kumar³⁷,Kumar Prashant¹²⁸

Affiliation:

1. Karkinos Foundation, Mumbai, Maharashtra, India

2. Karkinos Healthcare Pvt Ltd, Navi Mumbai, Maharashtra, India

3. Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India

4. Institute of Bioinformatics, Bangalore, Karnataka, India

5. Manipal Academy of Higher Education, Manipal, Karnataka, India

6. Department of Pathology, Tata Memorial Center, Mumbai, Maharashtra, India

7. Homi Bhabha National Institute, Training School Complex, Anushakti Nagar, Mumbai

8. Center of Excellence for Cancer – Gangwal School of Medical Sciences and Technology, Indian Institute of Technology Kanpur, Kanpur, Uttar Pradesh, India

Publisher

Medknow

Reference49 articles.

1. NUT Carcinoma: Clinicopathologic features, pathogenesis, and treatment;French;Pathol Int,2018

2. NUT midline carcinoma;French;Nat Rev Cancer,2014

3. NUT carcinoma: A rare case series;Das Majumdar;Indian J Cancer,2023

4. NUT midline carcinoma: A series of five cases, Including one with unusual clinical course;Kakkar;Head Neck Pathol,2018

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Authors’ reply to Das et al.;Cancer Research, Statistics, and Treatment;2024-04

2. NUT midline carcinoma: An unknown therapeutic territory;Cancer Research, Statistics, and Treatment;2024-04